Heparin is a commonly used blood thinner that has come under scrutiny for possible contamination. The FDA has recommended restricting the use of high doses of Heparin, or generally known as Bolus dosing in an attempt to limit the severity of adverse reactions to the drug. Bolus dosing is used to quickly thin blood in some patients.
The following people should be particularly aware of the Heparin contamination: hemodialysis patients, cardiovascular patients who have had surgery, photopheresis patients, plasapheresis patients and people who have had blood clots in their arteries.
There have been more than 350 complaints of adverse reactions to Heparin. The adverse reactions have been reported with the Heparin Sodium Injection multiple dose vials, 10 ml and 30 ml vials, 5000 units/ml, 10 ml vials and 10,000 units/ml, 4 ml vials. The following reactions have been reported shortly following the administration of Heparin:
- Severe allergic reactions
- Severe nausea
- Difficulty breathing
- Low blood pressure